EUVIMEDEUVIMED entdecken
Crossref

Neurological adverse effects of isoxazoline exposure in cats and dogs

Nicola Bates iD, Marieke A Dijkman iD, John Nicholas Edwards iD

Veterinary Record · 15.06.2024 · 194 (12)

DOI: 10.1002/vetr.4149 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary Record, online erschienen am 14.04.2024. Verfasst von Nicola Bates und 2 weiteren Autor:innen. Beteiligte Einrichtung: Veterinary Poisons Information Service, London, UK. Hauptthemen laut MEDLINE: Dog Diseases, Isoxazoles, Cat Diseases, Nervous System Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Isoxazolines are rarely reported to be associated with neurological adverse events in cats and dogs, but information about the onset and duration of neurological signs is lacking in the summary of product characteristics of these medicines.

Methods

The Veterinary Poisons Information Service and the Dutch Poisons Information Center databases were searched using the Veterinary Dictionary for Drug‐Related Affairs terms for ataxia, muscle tremor, convulsions or hyperesthesia in cats and dogs exposed to isoxazolines.

Results

There were 22 cases with and 57 cases without outcome information, mostly involving fluralaner or sarolaner. In both groups, muscle tremors and convulsions were the most common signs. In dogs, neurological signs occurred with oral therapeutic dose and overdosage. In cats, most fluralaner cases involved therapeutic topical exposure, and all sarolaner cases involved oral exposure. In all cases with outcome information, the animals recovered.

Limitations

Cases discussed with poison centres tend to involve more severe signs.

Conclusion

The true incidence of neurological adverse effects from isoxazolines remains unclear. The delay between the administration and onset of signs can be long, and the association may be missed. A lack of timing information in the summary of product characteristics could also contribute to missed attribution of adverse effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dog DiseasesIsoxazolesCat DiseasesNervous System DiseasesAnimalsDogsCatsPoison Control CentersFemaleMaleImidazoles

Substanzen

IsoxazolesA1443 compoundAWD 131-138Imidazoles

Autor:innen und Institutionen

  • Veterinary Poisons Information Service, London, UK.
  • Dutch Poisons Information Center, University Medical Center Utrecht, Utrecht, The Netherlands.

ORCID-Profile: Nicola Bates, Marieke A Dijkman, John Nicholas Edwards

Zitieren

APA

Bates, N., Dijkman, M. A., & Edwards, J. N. (2024). Neurological adverse effects of isoxazoline exposure in cats and dogs. Veterinary Record, 194(12). https://doi.org/10.1002/vetr.4149

Vancouver

Bates N, Dijkman MA, Edwards JN. Neurological adverse effects of isoxazoline exposure in cats and dogs. Veterinary Record. 2024;194(12). doi:10.1002/vetr.4149

BibTeX
@article{Bates2024,
  author = {Bates, Nicola and Dijkman, Marieke A and Edwards, John Nicholas},
  title = {Neurological adverse effects of isoxazoline exposure in cats and dogs},
  journal = {Veterinary Record},
  year = {2024},
  volume = {194},
  number = {12},
  doi = {10.1002/vetr.4149}
}
Kostenlos starten →